C12N 2710/16151
Methods of production or purification of viral material
C12N2710/16151 (Methods of production or purification of viral material) appears on 34 US grants and 59 published applications in this corpus.
Search patents in C12N- Granted patents
- 34
- Published applications
- 59
- Assignees
- 28
- Inventors
- 105
- Latest grant
- 14 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 4 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 1 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 2 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 1 | 1 |
| 2014 | 0 | 5 |
| 2015 | 2 | 5 |
| 2016 | 2 | 3 |
| 2017 | 2 | 6 |
| 2018 | 1 | 7 |
| 2019 | 6 | 5 |
| 2020 | 3 | 5 |
| 2021 | 2 | 4 |
| 2022 | 2 | 4 |
| 2023 | 3 | 5 |
| 2024 | 1 | 1 |
| 2025 | 2 | 4 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Recombinant cytomegalovirus vectors as vaccines for tuberculosis14 Oct 2025US 12,442,018 B2International AIDS Vaccine Initiative
- Genetically stable recombinant modified vaccinia Ankara (RMVA) vaccines and methods of preparation thereof24 Jun 2025US 12,337,032 B2City of Hope
- Scalable chromatography process for purification of human cytomegalovirus13 Aug 2024US 12,060,583 B2Merck Sharp & Dohme Corp.
- Recombinant cytomegalovirus vectors as vaccines for tuberculosis5 Dec 2023US 11,834,669 B2International AIDS Vaccine Initiative
- HCMV vaccine strain28 Feb 2023US 11,591,373 B2Universitätsmedizin der Johannes Gutenberg-Univsersität Mainz
- Methods for producing cmv vectors1 May 2025US 2025/0136949 A1Vir Biotechnology, Inc.
- Human cytomegalovirus rna vaccines13 Mar 2025US 2025/0082748 A1ModernaTX, Inc.
- Modified cytomegalovirus proteins and stabilized complexes9 Jan 2025US 2025/0009874 A1Glaxosmithkline Biologicals SA
- Scalable chromatography process for purification of human cytomegalovirus9 Jan 2025US 2025/0011732 A1Merck Sharp & Dohme Corp.
- Recombinant Cytomegalovirus Vectors As Vaccines For Tuberculosis9 May 2024US 2024/0150789 A1International AIDS Vaccine Inititative, Inc.
Most cited
By later US patents
- Human cytomegalovirus RNA vaccines130US 10,064,935 B2ModernaTX, Inc. · 2018
- Recombinant human cytomegalovirus vaccine22US 5,720,957 AAmerican Cyanamid Company · 1998
- Genetically stable recombinant modified vaccinia ankara (rMVA) vaccines and methods of preparation thereof20US 8,580,276 B2City of Hope · 2013
- Cells transformed or transfected with HCMV US2 gene12US 5,908,780 AAmerican Cyanamid Company · 1999
- Recombinant human cytomegalovirus having a US2 deletion9US 5,843,458 AAmerican Cyanamid Company · 1998